BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CMA Microdialysis AB to Sell DiLab, Inc.


6/30/2011 10:31:06 AM

Solna, Sweden, June 30th, 2011 -- DiLab is the pioneer and market leader in the field of Automated Blood Sampling (ABS) providing solutions to the Life Science Industry for over 20 years. The DiLab AccuSampler® systems are used in preclinical research in major pharmaceutical companies, contract research organizations and universities all over the world.

In 2010, CMA acquired DiLab and restructured the business to achieve historical profitability. CMA has invested in significant R&D to enable release of Dry Blood Spotting solutions, the AccuSampler® Micro Service Pack IV and the new 1.19 AccuSampler® Software suite.

VeruTech AB is a technology and development company based in Lund and headed by Mr. Hans Axel Hansson, the original founder of DiLab.

"I am very pleased to announce that DiLab is now back with its original founders. Hans-Axel Hansson is the true pioneer in this field and I am confident that VeruTech will continue to serve the market and develop innovative solutions as demanded by the Life Science industry“ said Philip Siberg, CEO of CMA.

Final closing is expected to occur no later than 15th of July 2011. Specific terms of the asset transaction will not be disclosed.

For more info please contact Philip Siberg, CEO, on +46 70 7906734 psi@microdialysis.se or Hans Axel Hansson on +46 46 211 2795, info@verutech.se

About CMA Microdialysis AB

CMA is a Swedish medical device and life science company founded in 1984. Unique and market leading solutions are developed, produced and sold to clinicians and researchers to enable optimized patient care and accelerated drug development. CMA’s complete line of instruments, consumables and computer software are used globally by universities, hospitals and pharmaceutical companies as unique tools for in vivo sampling and monitoring of organs and blood. The head office is located outside Stockholm, Sweden, with subsidiary in Boston, US. CMA has distributors across the globe, responsible for local sales, service and support. CMA is primarily owned by Investor AB and Bure AB, both leading Swedish industrial holding companies listed on the Stockholm Stock Exchange. For more info, see www.microdialysis.se

About VeruTech AB

VeruTech is Lund based technology and development company founded in 2008. The company is headed by Mr. Hans Axel Hansson, the original inventor of the AccuSampler system for Automated Blood Sampling. VeruTech offers products, service and solutions for the Life Science industry.

For more info, see www.verutech.se



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES